ALPHA TRIBE

Eris Lifesciences LimitedImportant, 09-06-2025: Updates

09-06-2025 | 05:36 pm

Eris Lifesciences has paid scheduled interest on its outstanding Non-Convertible Debentures, covering two tranches of Rs. 625 Cr each with Rs. 54.56 Cr interest annually. Timely payments highlight disciplined debt management and financial stability.

No comments yet. Be the first to comment!

All announcements from Eris Lifesciences Limited